A detailed history of Versant Capital Management, Inc transactions in Nevro Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 501 shares of NVRO stock, worth $1,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
501
Holding current value
$1,648
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$3.59 - $5.78 $1,798 - $2,895
501 New
501 $1,000
Q4 2023

Jan 08, 2024

BUY
$14.18 - $22.31 $354 - $557
25 Added 156.25%
41 $0
Q3 2023

Oct 11, 2023

SELL
$18.22 - $25.85 $546 - $775
-30 Reduced 65.22%
16 $0
Q2 2023

Jul 10, 2023

BUY
$22.62 - $39.32 $1,040 - $1,808
46 New
46 $1,000
Q1 2022

Apr 29, 2022

SELL
$59.95 - $92.06 $179 - $276
-3 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$70.23 - $144.31 $210 - $432
3 New
3 $0

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.